Among the whales there seems to swimming a lot of doubt and mixed speculation among the invested Photocorynus Spiniceps and the Paedocypris progenetica.
Could be due to the daily liquidity, trading volumes, almost zero silence from the company in between reports or the zero new contracts since January 2022.
If it’s from anything other than the facts it’s not based on anything LQMT did or is doing. Meaning the doubt being sewn around the www is self created each time speculation does not bare fruit.
It’s just as easy to be disappointed by LQMT’s own performance. To that end I don’t think LQMT needs more help in that area. In essence knowing that others might be successful in using the IP of LQMT or some other formula and both using LQMT’s partners abroad to manufacture parts, where LQMT has not shown any benefits from to date, IMHO, is not too helpful.
Staying positive through speculation is understandable. It’s not new. In fact it’s been going on since LQMT’s inception. Speculation about upcoming products by now seems to me like old news although the progress is new. It’s like driving forward, while still looking in the rear view mirror.
The real positives that exist are the capacity to manufacture, the infrastructure in Europe to distribute, the liquid assets and the conflicting Professor Li. The silence which is perceived to be negative. Might be a positive if there were more confidence in management.
My opinions are always worth less than the price of LQMT.
Good luck to all in LQMT.
The 10K does speak to a possibility of a one off whale, with no timeframe. The cash burn gives the final say on the timeline.
